HeartSciences (HSCS) Depreciation & Amortization (CF) (2021 - 2026)
HeartSciences filings provide 6 years of Depreciation & Amortization (CF) readings, the most recent being $6916.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 15.13% to $6916.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $28546.0, a 27.34% decrease, with the full-year FY2025 number at $37599.0, up 34.8% from a year prior.
- Depreciation & Amortization (CF) hit $6916.0 in Q1 2026 for HeartSciences, down from $7006.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $12215.0 in Q4 2024 to a low of $3717.0 in Q1 2024.
- Median Depreciation & Amortization (CF) over the past 5 years was $6916.0 (2026), compared with a mean of $7437.1.
- The widest YoY moves for Depreciation & Amortization (CF): up 61.68% in 2024, down 45.86% in 2024.
- HeartSciences' Depreciation & Amortization (CF) stood at $6813.0 in 2022, then rose by 12.08% to $7636.0 in 2023, then soared by 59.97% to $12215.0 in 2024, then crashed by 42.64% to $7006.0 in 2025, then fell by 1.28% to $6916.0 in 2026.
- The last three reported values for Depreciation & Amortization (CF) were $6916.0 (Q1 2026), $7006.0 (Q4 2025), and $7111.0 (Q3 2025) per Business Quant data.